Cargando…
Salmonid alphavirus replication in mosquito cells: towards a novel vaccine production system
Salmonid alphavirus (SAV) causes pancreas disease and sleeping disease in Atlantic salmon (Salmo salar) and rainbow trout (Oncorhynchus mykiss) and confers a major burden to the aquaculture industry. A commercial inactivated whole virus vaccine propagated in a salmon cell line at low temperature pro...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229328/ https://www.ncbi.nlm.nih.gov/pubmed/24418177 http://dx.doi.org/10.1111/1751-7915.12100 |
_version_ | 1782344126507778048 |
---|---|
author | Hikke, Mia C Verest, Marjan Vlak, Just M Pijlman, Gorben P |
author_facet | Hikke, Mia C Verest, Marjan Vlak, Just M Pijlman, Gorben P |
author_sort | Hikke, Mia C |
collection | PubMed |
description | Salmonid alphavirus (SAV) causes pancreas disease and sleeping disease in Atlantic salmon (Salmo salar) and rainbow trout (Oncorhynchus mykiss) and confers a major burden to the aquaculture industry. A commercial inactivated whole virus vaccine propagated in a salmon cell line at low temperature provides effective protection against SAV infections. Alphaviruses (family Togaviridae) are generally transmitted between vertebrate hosts via blood-sucking arthropod vectors, typically mosquitoes. SAV is unique in this respect because it can be transmitted directly from fish to fish and has no known invertebrate vector. Here, we show for the first time that SAV is able to complete a full infectious cycle within arthropod cells derived from the Asian tiger mosquito Aedes albopictus. Progeny virus is produced in C6/36 and U4.4. cells in a temperature-dependent manner (at 15°C but not at 18°C), can be serially passaged and remains infectious to salmonid Chinook salmon embryo cells. This suggests that SAV is not a vertebrate-restricted alphavirus after all and may have the potential to replicate in invertebrates. The current study also shows the ability of SAV to be propagated in mosquito cells, thereby possibly providing an alternative SAV production system for vaccine applications. |
format | Online Article Text |
id | pubmed-4229328 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BlackWell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-42293282014-12-10 Salmonid alphavirus replication in mosquito cells: towards a novel vaccine production system Hikke, Mia C Verest, Marjan Vlak, Just M Pijlman, Gorben P Microb Biotechnol Brief Report Salmonid alphavirus (SAV) causes pancreas disease and sleeping disease in Atlantic salmon (Salmo salar) and rainbow trout (Oncorhynchus mykiss) and confers a major burden to the aquaculture industry. A commercial inactivated whole virus vaccine propagated in a salmon cell line at low temperature provides effective protection against SAV infections. Alphaviruses (family Togaviridae) are generally transmitted between vertebrate hosts via blood-sucking arthropod vectors, typically mosquitoes. SAV is unique in this respect because it can be transmitted directly from fish to fish and has no known invertebrate vector. Here, we show for the first time that SAV is able to complete a full infectious cycle within arthropod cells derived from the Asian tiger mosquito Aedes albopictus. Progeny virus is produced in C6/36 and U4.4. cells in a temperature-dependent manner (at 15°C but not at 18°C), can be serially passaged and remains infectious to salmonid Chinook salmon embryo cells. This suggests that SAV is not a vertebrate-restricted alphavirus after all and may have the potential to replicate in invertebrates. The current study also shows the ability of SAV to be propagated in mosquito cells, thereby possibly providing an alternative SAV production system for vaccine applications. BlackWell Publishing Ltd 2014-09 2014-01-14 /pmc/articles/PMC4229328/ /pubmed/24418177 http://dx.doi.org/10.1111/1751-7915.12100 Text en © 2013 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology. http://creativecommons.org/licenses/by/3.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Brief Report Hikke, Mia C Verest, Marjan Vlak, Just M Pijlman, Gorben P Salmonid alphavirus replication in mosquito cells: towards a novel vaccine production system |
title | Salmonid alphavirus replication in mosquito cells: towards a novel vaccine production system |
title_full | Salmonid alphavirus replication in mosquito cells: towards a novel vaccine production system |
title_fullStr | Salmonid alphavirus replication in mosquito cells: towards a novel vaccine production system |
title_full_unstemmed | Salmonid alphavirus replication in mosquito cells: towards a novel vaccine production system |
title_short | Salmonid alphavirus replication in mosquito cells: towards a novel vaccine production system |
title_sort | salmonid alphavirus replication in mosquito cells: towards a novel vaccine production system |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229328/ https://www.ncbi.nlm.nih.gov/pubmed/24418177 http://dx.doi.org/10.1111/1751-7915.12100 |
work_keys_str_mv | AT hikkemiac salmonidalphavirusreplicationinmosquitocellstowardsanovelvaccineproductionsystem AT verestmarjan salmonidalphavirusreplicationinmosquitocellstowardsanovelvaccineproductionsystem AT vlakjustm salmonidalphavirusreplicationinmosquitocellstowardsanovelvaccineproductionsystem AT pijlmangorbenp salmonidalphavirusreplicationinmosquitocellstowardsanovelvaccineproductionsystem |